Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Journal of Patient-Reported Outcomes|August 28, 2018
Patients' experience of recurrent/metastatic head and neck squamous cell carcinoma and their perspective on the EORTC QLQ-C30 and QLQ-H&N35 questionnaires: a qualitative studyArnold Degboe, Sarah L Knight, Katarina Halling, et al.Seminars in Oncology|December 16, 2004
Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approachMarshall R Posner, Robert I Haddad, Lori Wirth, et al.Cancer|July 28, 2009
Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancerRobert Haddad, Stephen Sonis, Marshall Posner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Phase I study of C-TPF in patients with locally advanced squamous cell carcinoma of the head and neckRobert I Haddad, Roy B Tishler, Charles Norris, et al.Cancer Science|October 2, 2015
Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine-refractory differentiated thyroid cancerNaomi Kiyota, Martin Schlumberger, Kei Muro, et al.International Journal of Cancer|December 6, 2018
Anti-PD-1/PD-L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancerViswanath Gunda, Benjamin Gigliotti, Tameem Ashry, et al.The Oncologist|February 27, 2003
Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatmentRobert Haddad, Roy B Tishler, Charles M Norris, et al.The Oncologist|May 7, 2022
Phase II Study of Cabozantinib in Patients With Bone MetastasisEdwin Choy, Gregory M Cote, M Dror Michaelson, et al.Cancer|August 16, 2016
Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neckAntonio Jimeno, Jean-Pascal Machiels, Lori Wirth, et al.Viruses|January 25, 2025
Viral Transcript and Tumor Immune Microenvironment-Based Transcriptomic Profiling of HPV-Associated Head and Neck Squamous Cell Carcinoma Identifies Subtypes Associated with PrognosisAnastasiia Nikitina, Daria Kiriy, Andrey Tyshevich, et al.Pageof 4